undamentalytics Newsletter
Sign in

Scotts Miracle-gro Co (SMG) stock

Add to watchlist

Add holding +

NYSE: SMG NYSE Fertilizers & Agricultural Chemicals Next results ~November 4, 2026

C Fundamentals grade

Scotts Miracle-gro Co is a US-listed company in the fertilizers & agricultural chemicals industry. Its financial year ends in September.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: analysts' forecasts describe a different business from the one in the latest filings (spin-off, disposal or merger).

Price vs value

Under review: analysts' forecasts describe a different business from the one in the latest filings (spin-off, disposal or merger). We'll show the comparison once resolved.

Scotts Miracle-gro Co valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders1 buying, 3 selling1 purchase and 5 sales by directors and officers, last 12 monthsInsider trades
  • Funds237 adding, 190 cuttingOf 56 active managers that changed their stake, 32 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Scotts Miracle-gro files

Where Scotts Miracle-gro Co stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $3.48bn, up 4.6% on a year earlier, faster than 2.9% a quarter earlier. Free-cash-flow margin held at 7.6%. The diluted share count is up 3.2% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 1 of our 5 financial-health checks. At that price, our model says the market is pricing in cash flow shrinking about 4.1% a year for five years, faster than the -6.7% a year revenue growth it has delivered.

Our model value for Scotts Miracle-gro is under review, so past values are not shown until it is resolved.

Source: 10-Q filed August 5, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 4, 2026 (estimated)

Scotts Miracle-gro Co's trailing-twelve-month revenue grew 4.6% year on year, with a free-cash-flow margin of 7.6%. Where it lags: long-term debt as % of assets of 58.0% ranks 11 of 11 fertilizers & agricultural chemicals companies we cover.

Our discounted-cash-flow model values the business at ~$120 per share in the base case (~$82–$170 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 7.6% while net income grew 39.2%: a 32pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.

Things to watch

  • Share dilution. Diluted shares rose 3.2% in a year.
  • High earnings multiple. The shares trade at 52 times the last 12 months' earnings, so expectations are demanding.
  • Below peers: long-term debt as % of assets. Long-term debt as % of assets of 58.0% ranks 11 of 11 fertilizers & agricultural chemicals companies we cover (median 21.3%).
  • Below peers: stock pay as % of revenue. Stock pay as % of revenue of 1.4% ranks 8 of 9 fertilizers & agricultural chemicals companies we cover (median 0.6%).
  • Heavily shorted. 12.8% of the shares available to trade are sold short (4.8 days of average volume to cover).

Latest results: FY2026 Q3

Filed August 5, 2026
Earnings per share
$2.82 against an average estimate of $2.52: beat by 11.7%
Revenue
$1.17bn, up 1.1% on a year earlier
Share reaction
-6.6% in the first session after the results on July 29, 2026, against +0.1% for the S&P 500
Guidance given
non-GAAP adjusted diluted net income per share from continuing operations $4.3 to $4.45 (Full-Year Fiscal 2026); non-GAAP adjusted gross margin rate 32% (Full-Year Fiscal 2026)
Next report
November 4, 2026; average EPS estimate -$2.21

Scotts Miracle-gro's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+4.6%
  • 1 week+10.7%
  • 1 month+32.9%
  • This year+15.2%
  • 1 year+27.2%
  • 5 years-51.3%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$3.5B
Operating margin
11.0%
Net margin
2.1%
EPS (TTM, diluted)
$1.25

Growth

Revenue growth
+4.6%
Change in growth rate
+1.7 pts
Share count change
+3.2%

Cash

Free cash flow (TTM)
$263M
FCF margin
7.6%
Stock pay % of revenue
1.4%

Earnings

Last results
July 29, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Leadership
  2. Agreement ended
  3. Leadership
  4. Leadership
  5. Agreement
  6. Insider trade
  7. Results
  8. Guidance

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Scotts Miracle-gro Co valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: held for review: analysts' forecasts describe a different business from the one in the latest filings (spin-off, disposal or merger).

Our value per share comes from a discounted-cash-flow model of Scotts Miracle-gro Co's free cash flow after stock-based pay ( $551M, FY2026 Q3 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation multiples over time Market data may be delayed

At fiscal year end 2016201720182019202020212022202320242025Now
Share price$59.90$71.59$59.35$78.79$124.03$120.32$36.04$45.47$79.63$54.49$65.13
Market value$3.7bn$4.3bn$3.4bn$4.4bn$7.1bn$6.9bn$2.0bn$2.5bn$4.5bn$3.2bn$3.9bn
+ Net debt (− = net cash)$1.3bn$1.3bn$2.0bn$1.6bn$1.5bn$2.1bn$2.9bn$2.6bn$2.2bn$2.1bn$2.1bn
Enterprise value$5.0bn$5.6bn$5.4bn$6.1bn$8.6bn$9.0bn$4.9bn$5.1bn$6.7bn$5.3bn$6.0bn
Multiples
Price / sales 1.5x1.6x1.3x1.4x1.7x1.4x0.5x0.7x1.3x0.9x1.1x
Price / earnings 11.8x19.7x53.2x9.6x18.2x13.4x———22.0x52.2x
Price / free cash flow 20.0x14.7x12.4x24.1x14.2x41.8x—5.8x7.8x11.7x14.6x
EV / EBITDA 9.8x11.0x19.1x12.2x12.6x11.0x——23.1x12.5x13.4x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

54 /100

Moderate moat

How hard Scotts Miracle-gro's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 15 / 20

    Cash operating profit has been a median 11.8% of total assets over 10 years.

  • Pricing power 8 / 20

    Gross margin has been a median 31.2%, moving by 5.5 percentage points (standard deviation) across 10 years.

  • Durability 2 / 20

    Operating margin has been a median 10.6%; its worst year was -5.9%.

  • Cash conversion 13 / 20

    Free cash flow was positive in 9 of 10 years, at a median 7.6% of revenue.

  • Discipline 16 / 20

    The diluted share count rose 3.3% over five years; stock-based pay has been a median 1.4% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 4, 2026, before the open. Analysts expect revenue of $306m and EPS of −$2.21 (range −$2.39 to −$2.14) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $4.41 +18% $3.3bn −4%
Next $4.69 +6% $3.4bn +2%

Next year's EPS estimate has moved −0.4% in 90 days, across 8 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +1.6% on 90 days ago. In the last 30 days, 5 analysts raised Scotts Miracle-gro Co's forecast and 1 cut it.

Consensus EPS forecast Scotts Miracle-gro Co, last 90 days
$4.30 $4.40 $4.50 $4.60 $4.70 $4.80 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $4.35 Current fiscal year, 60 days ago: $4.42 Current fiscal year, 30 days ago: $4.42 Current fiscal year, 7 days ago: $4.41 Current fiscal year, Now: $4.41 $4.41 Next fiscal year, 90 days ago: $4.71 Next fiscal year, 60 days ago: $4.73 Next fiscal year, 30 days ago: $4.73 Next fiscal year, 7 days ago: $4.69 Next fiscal year, Now: $4.69 $4.69

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $4.35$4.71
60 days ago $4.42$4.73
30 days ago $4.42$4.73
7 days ago $4.41$4.69
Now $4.41$4.69

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 $2.52 $2.82 +11.7%
Mar 2026 $4.01 $4.53 +12.9%
Dec 2025 −$1.00 −$0.77 +23.3%
Sept 2025 −$1.98 −$1.96 +0.8%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, July 29, 2026
  • non-GAAP adjusted diluted net income per share from continuing operations Full-Year Fiscal 2026 $4.30 to $4.45 Non-GAAP Raised
    “The Company now expects non-GAAP adjusted diluted net income per share from continuing operations of $4.30 to $4.45.” source
  • Non-GAAP adjusted gross margin rate Full-Year Fiscal 2026 about 32% Non-GAAP Maintained
    “Non-GAAP adjusted gross margin rate of at least 32%” source
  • Free cash flow Full-Year Fiscal 2026 about $275m Maintained
    “Free cash flow of $275 million, driving leverage ratio down to the high 3s” source
  • full year tax rate full year 27% to 28%
    “Non-GAAP adjusted net income from continuing operations of $2.82 per diluted share improved by 8% over prior year, partially the result of the strong operating performance of our Bonnie Plants joint venture, and lower tax rate driven by higher earnings and discrete tax items as the Company expects its full year tax rate to range from 27-28% versus prior year of 29%.” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

Our model doesn't use the consensus here: consensus revenue is 0.71x the latest quarter's run rate while reported revenue grew 1% a year: a different business (spin-off, disposal or merger) - not used.

Analyst recommendations

8 analysts, Oct 2026
Buy675%
Hold225%
Sell00%

Monthly trend

  1. Oct 20261528
  2. Sep 20261438
  3. Aug 20261438
  4. Jul 2026448

Counts of recommendations published by analysts covering Scotts Miracle-gro Co, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
12.8%
of tradable shares
Days to cover
4.83
at average volume
Short interest, 1 month
+21%
to October 15, 2026
Held by institutions
89%
of shares
Held by insiders
23.7%
of shares
Employees
5,200
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Recent prices are available. Older price history and the statistics that need it are being loaded in the background.

What moved the share price

Last 12 months +27.2%

$51.21 on October 31, 2025 to $65.13

ThenNowEffect
Revenue (last 12 months) $3.3bn $3.5bn +4.6%
Net margin 1.6% 2.1% +33.1%
P/E multiple 55.3x 52.2x −5.7%
Share count 57m 59m −3.1%

Biggest factor: net margin.

Last 3 years +36.3%

$47.77 on November 3, 2023 to $65.13

ThenNowEffect
Revenue (last 12 months) $3.7bn $3.5bn −5.1%
P/S multiple 0.7x 1.1x +51.9%
Share count 56m 59m −5.4%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
SMG−18%−69%+37%+8%−8%+15%
Industry peers (median)+72%+22%−17%−8%+1%+12%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
SMG33%25%42%50%42%55%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
SMG−46%−75%−48%−30%−37%−33%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since October 29, 2015: 84% from April 5, 2021 to October 11, 2022. Getting back needed a 508% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$48.44 – $72.68
From 52-week high
−10.4%
vs 50-day average
+17.6%
vs 200-day average
+6.8%
Volatility (1 year)
39%
Beta vs S&P 500
0.66

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
5 up, 7 down
typical move ±5.1%
After a week
5 up, 7 down
typical move ±6.4%
After a month
6 up, 6 down
typical move ±10.2%
Results releasedNext dayS&P 500 next day5 days21 days
July 29, 2026 −6.6% +0.1% −9.5% −16.2%
April 29, 2026 −4.1% +1.0% −3.9% −8.7%
February 20, 2026 0.0% −0.3% +1.4% −5.0%
January 28, 2026 +3.5% −0.2% +2.3% +12.0%
November 5, 2025 +3.7% −0.7% +7.4% +0.1%
July 30, 2025 −7.7% −0.5% −10.8% −8.7%
April 30, 2025 −0.3% +0.7% +0.6% +12.5%
April 28, 2025 +0.9% +0.7% +5.8% +14.0%
January 29, 2025 −5.0% +0.1% −8.2% −21.8%
November 6, 2024 −21.9% +3.3% −22.1% −18.6%
July 31, 2024 +7.1% +0.2% −2.3% +2.1%
May 1, 2024 +0.2% +0.6% −2.9% +2.7%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Scotts Miracle-gro Co in five measures

Fundamentals grade C
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Scotts Miracle-gro Co
$3.3B $3.4B $3.5B $3.6B FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $3.6B Revenue (TTM), FY24 Q1: $3.4B Revenue (TTM), FY24 Q2: $3.4B Revenue (TTM), FY24 Q3: $3.5B Revenue (TTM), FY24 Q4: $3.6B Revenue (TTM), FY25 Q1: $3.5B Revenue (TTM), FY25 Q2: $3.4B Revenue (TTM), FY25 Q3: $3.3B Revenue (TTM), FY25 Q4: $3.4B Revenue (TTM), FY26 Q1: $3.4B Revenue (TTM), FY26 Q2: $3.5B Revenue (TTM), FY26 Q3: $3.5B $3.5B

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $3.6B
FY24 Q1 $3.4B
FY24 Q2 $3.4B
FY24 Q3 $3.5B
FY24 Q4 $3.6B
FY25 Q1 $3.5B
FY25 Q2 $3.4B
FY25 Q3 $3.3B
FY25 Q4 $3.4B
FY26 Q1 $3.4B
FY26 Q2 $3.5B
FY26 Q3 $3.5B
Revenue growth, TTM YoY Scotts Miracle-gro Co
-15% -10% -5% 0% 5% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: -9.5% Revenue growth, TTM YoY, FY24 Q1: -11.6% Revenue growth, TTM YoY, FY24 Q2: -8.3% Revenue growth, TTM YoY, FY24 Q3: -4.3% Revenue growth, TTM YoY, FY24 Q4: 0.0% Revenue growth, TTM YoY, FY25 Q1: 2.1% Revenue growth, TTM YoY, FY25 Q2: -1.6% Revenue growth, TTM YoY, FY25 Q3: -5.2% Revenue growth, TTM YoY, FY25 Q4: -3.9% Revenue growth, TTM YoY, FY26 Q1: -3.1% Revenue growth, TTM YoY, FY26 Q2: 2.9% Revenue growth, TTM YoY, FY26 Q3: 4.6% 4.6%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 -9.5%
FY24 Q1 -11.6%
FY24 Q2 -8.3%
FY24 Q3 -4.3%
FY24 Q4 0.0%
FY25 Q1 2.1%
FY25 Q2 -1.6%
FY25 Q3 -5.2%
FY25 Q4 -3.9%
FY26 Q1 -3.1%
FY26 Q2 2.9%
FY26 Q3 4.6%
Operating margin (TTM) Scotts Miracle-gro Co
-10% -5% 0% 5% 10% 15% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Operating margin (TTM), FY23 Q4: -4.9% Operating margin (TTM), FY24 Q1: -5.2% Operating margin (TTM), FY24 Q2: -3.3% Operating margin (TTM), FY24 Q3: 0.3% Operating margin (TTM), FY24 Q4: 5.9% Operating margin (TTM), FY25 Q1: 6.0% Operating margin (TTM), FY25 Q2: 8.5% Operating margin (TTM), FY25 Q3: 9.3% Operating margin (TTM), FY25 Q4: 10.5% Operating margin (TTM), FY26 Q1: 11.3% Operating margin (TTM), FY26 Q2: 12.5% Operating margin (TTM), FY26 Q3: 11.0% 11.0%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q4 -4.9%
FY24 Q1 -5.2%
FY24 Q2 -3.3%
FY24 Q3 0.3%
FY24 Q4 5.9%
FY25 Q1 6.0%
FY25 Q2 8.5%
FY25 Q3 9.3%
FY25 Q4 10.5%
FY26 Q1 11.3%
FY26 Q2 12.5%
FY26 Q3 11.0%
FCF margin (TTM) Scotts Miracle-gro Co
0% 10% 20% 30% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: 12.3% FCF margin (TTM), FY24 Q1: 15.1% FCF margin (TTM), FY24 Q2: 28.1% FCF margin (TTM), FY24 Q3: 28.4% FCF margin (TTM), FY24 Q4: 16.4% FCF margin (TTM), FY25 Q1: 14.0% FCF margin (TTM), FY25 Q2: 11.3% FCF margin (TTM), FY25 Q3: 7.3% FCF margin (TTM), FY25 Q4: 8.0% FCF margin (TTM), FY26 Q1: 10.5% FCF margin (TTM), FY26 Q2: 10.9% FCF margin (TTM), FY26 Q3: 7.6% 7.6%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 12.3%
FY24 Q1 15.1%
FY24 Q2 28.1%
FY24 Q3 28.4%
FY24 Q4 16.4%
FY25 Q1 14.0%
FY25 Q2 11.3%
FY25 Q3 7.3%
FY25 Q4 8.0%
FY26 Q1 10.5%
FY26 Q2 10.9%
FY26 Q3 7.6%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

Each dollar Scotts Miracle-gro took in during FY2025, followed through to profit: what it cost to make, what went on research and running the business, and what was left after tax.

  1. Revenue $3.4B
  2. Cost of revenue $2.3B · 68.8%
  3. Gross profit $1B · 30.6%
  4. Research and development $34.8M · 1.0%
  5. Selling, general and admin $603M · 17.7%
  6. Other operating costs $47.4M · 1.4%
  7. Operating income $359M · 10.5%
  8. Income tax $76.5M · 2.2%
  9. Interest and other $137M · 4.0%
  10. Net income $145M · 4.3%

Shares of revenue. Source: Scotts Miracle-gro's 10-K for FY2025, as filed with the SEC. "Other" lines are what the reported lines leave unexplained.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Sept 2009 2010 Sept 2010 2011 Sept 2011 2012 Sept 2012 2013 Sept 2013 2014 Sept 2014 2015 Sept 2015 2016 Sept 2016 2017 Sept 2017 2018 Sept 2018 2019 Sept 2019 2020 Sept 2020 2021 Sept 2021 2022 Sept 2022 2023 Sept 2023 2024 Sept 2024 2025 Sept 2025 LTM Jun 2026
Income
Revenue 2,746 2,873 2,800 2,771 2,774 2,841 3,017 2,506 2,642 2,663 3,156 4,132 4,925 3,924 3,551 3,553 3,413 3,483
Gross profit 978 1,086 1,009 957 978 890 811 900 973 865 1,020 1,347 1,469 873 657 851 1,044 1,106
EBITDA 308 423 325 304 377 344 307 510 507 282 499 680 817 −329 −82 289 421 445
Operating income 261 374 275 241 311 284 254 448 433 199 410 585 723 −434 −174 209 359 383
Net income 153 204 168 107 161 167 160 315 218 64 461 387 513 −438 −380 −35 145 74
Diluted EPS $2.32 $3.02 $2.54 $1.71 $2.57 $2.65 $2.57 $5.09 $3.63 $1.12 $8.18 $6.81 $8.96 −$7.88 −$6.79 −$0.61 $2.47 $1.25
Growth (year on year)
Revenue −2.7% +4.6% −2.6% −1.0% +0.1% +2.4% +6.2% −16.9% +5.4% +0.8% +18.5% +30.9% +19.2% −20.3% −9.5% +0.0% −3.9% +4.6%
EBITDA +59.2% +37.1% −23.1% −6.6% +24.0% −8.6% −10.7% +65.9% −0.5% −44.3% +76.7% +36.3% +20.1% −140.3% — — +45.6% +14.6%
Operating income +86.3% +43.7% −26.6% −12.2% +28.7% −8.6% −10.5% +76.4% −3.2% −54.1% +105.9% +42.9% +23.5% −160.0% — — +71.7% +23.5%
Net income — +33.1% −17.7% −36.6% +51.3% +3.4% −4.0% +97.3% −30.8% −70.8% +623.2% −15.9% +32.3% −185.4% — — — —
Diluted EPS — +30.2% −15.9% −32.7% +50.3% +3.1% −3.0% +98.1% −28.7% −69.1% +630.4% −16.7% +31.6% −187.9% — — — —
Margins
Gross margin 35.6% 37.8% 36.0% 34.5% 35.3% 31.3% 26.9% 35.9% 36.8% 32.5% 32.3% 32.6% 29.8% 22.2% 18.5% 23.9% 30.6% 31.8%
EBITDA margin 11.2% 14.7% 11.6% 11.0% 13.6% 12.1% 10.2% 20.3% 19.2% 10.6% 15.8% 16.5% 16.6% −8.4% −2.3% 8.1% 12.3% 12.8%
Operating margin 9.5% 13.0% 9.8% 8.7% 11.2% 10.0% 8.4% 17.9% 16.4% 7.5% 13.0% 14.2% 14.7% −11.1% −4.9% 5.9% 10.5% 11.0%
Net margin 5.6% 7.1% 6.0% 3.8% 5.8% 5.9% 5.3% 12.6% 8.3% 2.4% 14.6% 9.4% 10.4% −11.1% −10.7% −1.0% 4.3% 2.1%
Free-cash-flow margin 7.0% 7.4% 1.8% 3.0% 10.2% 5.4% 6.1% 7.4% 11.1% 10.3% 5.8% 12.0% 3.3% −6.2% 12.3% 16.4% 8.0% 7.6%
Cash flow
Cash from operations 265 296 122 153 342 241 247 244 363 343 227 558 272 −129 531 668 371 369
Capital spending 72 83 73 69 60 88 62 58 70 68 42 63 107 114 93 84 97 106
Free cash flow 193 213 49 84 282 153 185 186 294 274 184 495 165 −243 438 584 274 263
Stock-based pay 15 16 16 13 10 11 13 16 25 40 38 58 41 34 69 80 69 50
Free cash flow after stock pay 178 196 33 72 272 142 172 170 268 234 146 437 124 −277 369 503 205 214
Balance sheet
Cash 71 88 131 132 130 65 51 29 121 34 19 17 244 87 32 72 33 28
Total debt 810 — 795 783 571 784 1,158 1,316 1,410 2,026 1,666 1,531 2,315 2,992 2,631 2,243 2,120 2,126
Net debt (negative = net cash) 740 −88 664 651 441 719 1,107 1,288 1,289 1,992 1,647 1,515 2,071 2,905 2,599 2,171 2,087 2,098
Diluted shares 66m 68m 66m 62m 63m 63m 62m 62m 60m 57m 56m 57m 57m 56m 56m 57m 59m 59m
Returned to shareholders
Dividends 33 43 68 75 88 231 111 117 120 120 125 411 143 166 149 151 154 154
Buybacks — 25 359 18 0 120 15 137 255 328 3 53 129 258 9 5 18 12
Total returned 33 68 427 93 88 351 126 254 376 448 128 464 272 424 158 156 173 167

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

1 of 5 checks passed · June 27, 2026
What it owns · $3.2bn
Short-term assets $1.3bnLonger-term assets $1.8bn
What it owes, and who funded it · $3.4bn
Short-term liabilities $1.1bnLonger-term liabilities $2.3bnShareholders' equity $-209m
  • Short-term assets cover short-term liabilities $1.3bn of assets due within a year against $1.1bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities $1.3bn short-term assets against $2.3bn of longer-dated liabilities.
  • More cash than debt $28m of cash against $2.1bn of debt.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt $369m of operating cash flow against $2.1bn of debt.
  • Operating profit covers interest at least five times over Operating income of $382m against $113m of interest.

From Scotts Miracle-gro Co's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2026 Q3 TTM
Buybacks (TTM)
$12.1M
Dividends (TTM)
$154M
Returned to shareholders
63%
of free cash flow
Buybacks, last 3 fiscal years
$32.8M
Diluted share count
+3.2%
year over year
Total shareholder yield
4.4%
dividends 4.1% + buybacks 0.3% of market value
Dividend payout ratio
209%
of net income paid out
Sales & admin spending
17.7%
of revenue
Days sales outstanding
75 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in fertilizers & agricultural chemicals
Last 12 months unless stated SMG FMC ICL CF MOS CTVA Median
Revenue, last 12 months $3.5bn $2.8bn $7.2bn $7.7bn $12.2bn $17.8bn $3.5bn
Revenue growth, last 12 months 4.6% −22.0% 4.6% 20.0% 8.8% 3.7% 3.7%
Revenue growth, 3-year average −1.7% −17.2% — −3.9% −10.0% 0.5% −4.2%
Revenue growth, latest quarter 1.1% −80.5% — 17.6% −6.0% −1.2% −1.2%
Gross margin 31.8% 22.0% 30.6% 42.5% 11.0% 49.5% 31.0%
Operating margin 11.0% −97.0% 8.1% 41.1% −1.4% — 3.4%
Operating margin, 3-year average 6.8% −29.8% 12.4% 32.7% 4.2% — 6.8%
Net margin 2.1% −151.2% 3.2% 27.1% −5.2% 5.7% 2.1%
Cash from operations / revenue 10.6% 15.1% 14.8% 38.5% 3.6% 6.8% 14.8%
Free-cash-flow margin 7.6% 13.1% 4.6% 24.7% −7.7% 3.5% 7.4%
Free-cash-flow margin, 3-year average 14.4% 5.8% 7.0% 26.0% −1.3% 9.2% 9.1%
Stock pay / revenue 1.4% 0.9% 0.2% 0.6% 0.3% 0.5% 0.6%
Change in share count 3.2% 1.5% 0.1% −8.6% −0.1% −1.9% 0.1%

Median of all 11 companies we cover in fertilizers & agricultural chemicals. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

11 fertilizers & agricultural chemicals companies
Measure Company Peer median Rank
Revenue growth Growth 4.6% 3.7% 4 of 11
Change in growth rate Growth +1.7pp -0.8pp 4 of 11
Gross margin Profitability 31.8% 31.0% 5 of 11
Operating margin Profitability 11.0% 8.1% 4 of 9
Net margin Profitability 2.1% 2.1% 6 of 11
Free-cash-flow margin Cash generation 7.6% 7.4% 5 of 11
Stock pay as % of revenue Cash generation 1.4% 0.6% 8 of 9
Long-term debt as % of assets Balance sheet 58.0% 21.3% 11 of 11
Change in share count Balance sheet 3.2% 0.1% 10 of 11
Days sales outstanding Balance sheet 75 days 75 days 4 of 7

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to September 30, 2025
Segments
Line of business Revenue Share YoY
Reportable Segment Aggregation Before Other Operating $3.2B 92.6% ▼ 4.5%
All Other Segments $254M 7.4% ▲ 3.8%
Geography
Region Revenue Share YoY
United States $3.1B 91.8% ▼ 3.5%
International $279M 8.2% ▼ 8.6%

From Scotts Miracle-gro Co's 10-K filed November 25, 2025, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$3.4B
Institutions reporting
462
Shares held vs prior quarter
▲ 9.0%
Positions opened / closed
72 / 52

Top buyers and sellers, Q2 2026: 237 institutions bought and 190 sold ; the biggest buyer was FMR LLC (+2.0M shares) and the biggest seller Captrust Financial Advisors (−1.1M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $304M 4.5M 8.9% ▲ 0.4%
FMR LLC $279M 4.1M 8.1% ▲ 91.3%
Earnest Partners LLC $247M 3.6M 7.2% ▲ 6.8%
Vanguard Portfolio Management LLC $165M 2.4M 4.8% ▼ 3.1%
Vanguard Capital Management LLC $135M 2.0M 3.9% ▲ 1.0%
State Street Corp $109M 1.6M 3.2% ▲ 5.4%
Ameriprise Financial Inc $108M 1.6M 3.1% ▲ 12.3%
Ariel Investments, LLC $96.1M 1.4M 2.8% ▲ 46.6%
Brandes Investment Partners, LP $91M 1.3M 2.7% ▲ 65.2%
Quantinno Capital Management LP $87M 1.3M 2.5% ▲ 486.3%
Arrowstreet Capital, Limited Partnership $83.6M 1.2M 2.4% ▼ 4.8%
Epoch Investment Partners, Inc. $83.3M 1.2M 2.4% ▲ 48.6%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Scotts Miracle-gro Co's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $49,508 1 trade by 1 insider, last 12 months Insider sales History → $5.5M 5 trades by 3 insiders · 0% under pre-set plans
Net ▼ $5.4M net selling
Insider Date Trade Shares Price Value
Kingdon Mark D Director August 10, 2026 Sell 831 $61.65 $51,231
Hagedorn Partnership, L.P. Director August 3, 2026 Sell 28,793 $67.42 $1.9M
Hagedorn Partnership, L.P. Director August 3, 2026 Sell 1,207 $68.16 $82,269
Johnson Stephen L Director July 30, 2026 Sell 1,171 $68.32 $80,000
Scheiwer Mark J EVP, CFO & CAO February 24, 2026 Buy 693 $71.44 $49,508
Hagedorn Partnership, L.P. Director February 12, 2026 Sell 50,000 $66.40 $3.3M

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 8 trades and filings

No trades in Scotts Miracle-gro Co disclosed in the last 12 months; 8 earlier trades on record.

  • Susie Lee(D-NV 3):Sale (full), $1,001 - $15,000, traded November 30, 2022, filed December 29, 2022
  • Susie Lee(D-NV 3):Sale (full), $1,001 - $15,000, traded June 5, 2020, filed July 10, 2020
  • Susie Lee(D-NV 3):Purchase, $1,001 - $15,000, traded April 7, 2020, filed June 15, 2020

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around October 23, 2026 estimated from the company's past filing pattern, not announced

  • July 29, 2026
  • April 29, 2026
  • February 20, 2026
  • January 28, 2026
  • November 5, 2025
  • July 30, 2025

Recent SEC filings

Data status

When each part of this page on Scotts Miracle-gro Co was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Scotts Miracle-gro Co in brief

What does Scotts Miracle-gro Co do?
Scotts Miracle-gro Co is a US-listed company in the fertilizers & agricultural chemicals industry. Its financial year ends in September.
What is Scotts Miracle-gro Co's stock ticker?
Scotts Miracle-gro Co trades under the ticker SMG on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Scotts Miracle-gro Co's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Scotts Miracle-gro Co reported revenue of $3.5B, 4.6% higher than a year earlier, according to its SEC filings.
What is Scotts Miracle-gro Co's free cash flow?
Scotts Miracle-gro Co's free-cash-flow margin is 7.6% of revenue over the trailing twelve months, ranking 5 of the 11 fertilizers & agricultural chemicals companies we cover.
Who are Scotts Miracle-gro Co's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., FMR LLC and Earnest Partners LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Scotts Miracle-gro Co buying back stock, and does it pay a dividend?
Scotts Miracle-gro Co spent $12.1M on share repurchases over the trailing twelve months, and its diluted share count still rose 3.2% over the year.
What is Scotts Miracle-gro Co's market cap?
On November 2, 2026, Scotts Miracle-gro Co's market capitalisation was about $3.9B, with a price-to-earnings ratio of 52.2 and net debt of $2.1B. Market figures come from third-party market data and may be delayed.
Does Scotts Miracle-gro Co pay a dividend?
Yes: Scotts Miracle-gro Co paid $154M in dividends over the trailing twelve months, a dividend yield of 4.07% and a payout ratio of 208.9%.
Who are Scotts Miracle-gro Co's competitors?
In our Fertilizers & Agricultural Chemicals peer group, the companies closest to Scotts Miracle-gro Co are FMC Corp, ICL Group Ltd., CF Industries, The Mosaic Company and Corteva, Inc. The side-by-side comparison below sets their revenue, margins and growth against Scotts Miracle-gro Co's.
Are insiders buying or selling Scotts Miracle-gro Co stock?
Over the last 12 months, Scotts Miracle-gro Co's directors and officers reported 1 open-market purchases and 5 sales on Form 4. The insider trading page charts every trade.
When is Scotts Miracle-gro Co's next earnings date?
Around November 4, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Scotts Miracle-gro Co announces its own schedule.